Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04323735 · ClinicalTrials.gov registry record · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
A Phase 2 study of Neurogenic Bladder, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 182
- Enrollment target
- 1
- Study location
NCT04323735 is a Phase 2 study of Neurogenic Bladder that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 182 participants, above the 82-participant average among 16 other Neurogenic Bladder trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04323735, a Phase 2 study of Neurogenic Bladder, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of the proposed research among this population are: 1) to define clinically meaningful change (i.e. differentiating states of health and illness) with respect to urinary symptoms, urine inflammation, cultivable bacteria, and the urine ecosystem; and 2) to determine the optimal intravesical Lactobacillus RhamnosusGG (LGG®) dose to be used to reduce urinary symptoms in a future clinical trial.
Conditions Studied
Interventions
- DRUG Culturelle 10 Billion CFU Capsule
Study Locations (1)
District of Columbia
- MedStar National Rehabilitation Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2026-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04323735
The ClinicalTrials.gov registry entry for NCT04323735 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 82-participant average among 16 other Neurogenic Bladder trials with a reported enrollment target (122% higher). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurogenic Bladder appearing as the primary indexed condition, and to 1 intervention - of which Culturelle 10 Billion CFU Capsule is the first listed.
NCT04323735 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04323735 about?
NCT04323735 is a clinical study titled "Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters". The objectives of the proposed research among this population are: 1) to define clinically meaningful change (i.e. differentiating states of health and illness) with respect to urinary symptoms, urine inflammation, cultivable bacteria, and the urine ecosystem; and 2) to determine the optimal intrave...
What is the current status of trial NCT04323735?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 182 participants. The study started on 2020-01-10. Estimated completion is 2026-09.
What conditions does trial NCT04323735 study?
This clinical trial studies the following conditions: Neurogenic Bladder.
What interventions are being tested in trial NCT04323735?
The interventions under investigation include: Culturelle 10 Billion CFU Capsule (DRUG).
Who is sponsoring clinical trial NCT04323735?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04323735 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurogenic Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intravesical LGG VS Saline Bladder Wash RCT
RECRUITING · Phase 2
-
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
RECRUITING · Early Phase 1
-
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
RECRUITING
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
Vascularized Composite Bladder Allograft Transplantation
RECRUITING · NA
-
Concomitant Renal and Urinary Bladder Allograft Transplantation
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.